Tygh Capital Management, Inc. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tygh Capital Management, Inc. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q1 2020$3,475,000
+33.7%
51,600
+67.3%
0.78%
+81.6%
Q4 2019$2,599,000
-39.3%
30,847
-75.9%
0.43%
-52.2%
Q4 2018$4,285,000
-61.9%
127,973
-40.3%
0.90%
-51.1%
Q3 2018$11,236,000
+43.2%
214,431
-14.5%
1.84%
+38.2%
Q2 2018$7,849,000250,7691.33%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders